rs35083095

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_182760.4(SUMF1):​c.*10A>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.487 in 1,611,632 control chromosomes in the GnomAD database, including 195,194 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.43 ( 15387 hom., cov: 34)
Exomes 𝑓: 0.49 ( 179807 hom. )

Consequence

SUMF1
NM_182760.4 3_prime_UTR

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -1.18

Publications

18 publications found
Variant links:
Genes affected
SUMF1 (HGNC:20376): (sulfatase modifying factor 1) This gene encodes an enzyme that catalyzes the hydrolysis of sulfate esters by oxidizing a cysteine residue in the substrate sulfatase to an active site 3-oxoalanine residue, which is also known as C-alpha-formylglycine. Mutations in this gene cause multiple sulfatase deficiency, a lysosomal storage disorder. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
SUMF1 Gene-Disease associations (from GenCC):
  • mucosulfatidosis
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Orphanet, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, ClinGen, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 3-4362134-T-C is Benign according to our data. Variant chr3-4362134-T-C is described in ClinVar as Benign. ClinVar VariationId is 96557.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.596 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SUMF1NM_182760.4 linkc.*10A>G 3_prime_UTR_variant Exon 9 of 9 ENST00000272902.10 NP_877437.2 Q8NBK3-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SUMF1ENST00000272902.10 linkc.*10A>G 3_prime_UTR_variant Exon 9 of 9 1 NM_182760.4 ENSP00000272902.5 Q8NBK3-1

Frequencies

GnomAD3 genomes
AF:
0.431
AC:
65440
AN:
151908
Hom.:
15383
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.227
Gnomad AMI
AF:
0.588
Gnomad AMR
AF:
0.527
Gnomad ASJ
AF:
0.546
Gnomad EAS
AF:
0.613
Gnomad SAS
AF:
0.477
Gnomad FIN
AF:
0.524
Gnomad MID
AF:
0.475
Gnomad NFE
AF:
0.492
Gnomad OTH
AF:
0.473
GnomAD2 exomes
AF:
0.503
AC:
125370
AN:
249268
AF XY:
0.503
show subpopulations
Gnomad AFR exome
AF:
0.218
Gnomad AMR exome
AF:
0.601
Gnomad ASJ exome
AF:
0.533
Gnomad EAS exome
AF:
0.626
Gnomad FIN exome
AF:
0.518
Gnomad NFE exome
AF:
0.497
Gnomad OTH exome
AF:
0.507
GnomAD4 exome
AF:
0.493
AC:
719494
AN:
1459604
Hom.:
179807
Cov.:
35
AF XY:
0.493
AC XY:
358050
AN XY:
726188
show subpopulations
African (AFR)
AF:
0.216
AC:
7226
AN:
33454
American (AMR)
AF:
0.587
AC:
26226
AN:
44700
Ashkenazi Jewish (ASJ)
AF:
0.526
AC:
13740
AN:
26116
East Asian (EAS)
AF:
0.625
AC:
24784
AN:
39666
South Asian (SAS)
AF:
0.475
AC:
40975
AN:
86196
European-Finnish (FIN)
AF:
0.519
AC:
27706
AN:
53346
Middle Eastern (MID)
AF:
0.492
AC:
2759
AN:
5610
European-Non Finnish (NFE)
AF:
0.493
AC:
546951
AN:
1110216
Other (OTH)
AF:
0.483
AC:
29127
AN:
60300
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
16853
33705
50558
67410
84263
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16038
32076
48114
64152
80190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.431
AC:
65465
AN:
152028
Hom.:
15387
Cov.:
34
AF XY:
0.435
AC XY:
32356
AN XY:
74312
show subpopulations
African (AFR)
AF:
0.227
AC:
9417
AN:
41524
American (AMR)
AF:
0.527
AC:
8061
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.546
AC:
1894
AN:
3468
East Asian (EAS)
AF:
0.614
AC:
3163
AN:
5152
South Asian (SAS)
AF:
0.476
AC:
2294
AN:
4822
European-Finnish (FIN)
AF:
0.524
AC:
5522
AN:
10548
Middle Eastern (MID)
AF:
0.466
AC:
137
AN:
294
European-Non Finnish (NFE)
AF:
0.492
AC:
33445
AN:
67920
Other (OTH)
AF:
0.473
AC:
999
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1839
3678
5518
7357
9196
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
610
1220
1830
2440
3050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.459
Hom.:
8549
Bravo
AF:
0.428
Asia WGS
AF:
0.506
AC:
1759
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Apr 26, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Multiple sulfatase deficiency Benign:3
Nov 18, 2019
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
1.0
DANN
Benign
0.39
PhyloP100
-1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35083095; hg19: chr3-4403818; COSMIC: COSV55991862; API